| Product Code: ETC9956279 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Temporal Arteritis Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Temporal Arteritis Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Temporal Arteritis Market - Industry Life Cycle |
3.4 United Kingdom (UK) Temporal Arteritis Market - Porter's Five Forces |
3.5 United Kingdom (UK) Temporal Arteritis Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.6 United Kingdom (UK) Temporal Arteritis Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 United Kingdom (UK) Temporal Arteritis Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 United Kingdom (UK) Temporal Arteritis Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United Kingdom (UK) Temporal Arteritis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence and prevalence of temporal arteritis in the UK due to an aging population. |
4.2.2 Advances in medical technology and diagnostic tools improving early detection and treatment options. |
4.2.3 Growing awareness among healthcare professionals leading to better diagnosis and management of temporal arteritis. |
4.3 Market Restraints |
4.3.1 Limited treatment options available for temporal arteritis in the UK. |
4.3.2 High cost associated with the treatment and management of temporal arteritis leading to affordability issues for patients. |
4.3.3 Lack of specific guidelines and protocols for the management of temporal arteritis in the UK healthcare system. |
5 United Kingdom (UK) Temporal Arteritis Market Trends |
6 United Kingdom (UK) Temporal Arteritis Market, By Types |
6.1 United Kingdom (UK) Temporal Arteritis Market, By Treatment |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Temporal Arteritis Market Revenues & Volume, By Treatment, 2021- 2031F |
6.1.3 United Kingdom (UK) Temporal Arteritis Market Revenues & Volume, By Corticosteroids, 2021- 2031F |
6.1.4 United Kingdom (UK) Temporal Arteritis Market Revenues & Volume, By Aristocort, 2021- 2031F |
6.1.5 United Kingdom (UK) Temporal Arteritis Market Revenues & Volume, By Bubbli-Pred, 2021- 2031F |
6.1.6 United Kingdom (UK) Temporal Arteritis Market Revenues & Volume, By Immunosuppressive Agents, 2021- 2031F |
6.1.7 United Kingdom (UK) Temporal Arteritis Market Revenues & Volume, By Adalimumab, 2021- 2031F |
6.1.8 United Kingdom (UK) Temporal Arteritis Market Revenues & Volume, By Infliximab, 2021- 2031F |
6.2 United Kingdom (UK) Temporal Arteritis Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Temporal Arteritis Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 United Kingdom (UK) Temporal Arteritis Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3 United Kingdom (UK) Temporal Arteritis Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Temporal Arteritis Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 United Kingdom (UK) Temporal Arteritis Market Revenues & Volume, By Homecare, 2021- 2031F |
6.3.4 United Kingdom (UK) Temporal Arteritis Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.3.5 United Kingdom (UK) Temporal Arteritis Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United Kingdom (UK) Temporal Arteritis Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Temporal Arteritis Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 United Kingdom (UK) Temporal Arteritis Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.4.4 United Kingdom (UK) Temporal Arteritis Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 United Kingdom (UK) Temporal Arteritis Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Temporal Arteritis Market Export to Major Countries |
7.2 United Kingdom (UK) Temporal Arteritis Market Imports from Major Countries |
8 United Kingdom (UK) Temporal Arteritis Market Key Performance Indicators |
8.1 Average time from symptom onset to diagnosis of temporal arteritis in the UK. |
8.2 Number of healthcare professionals receiving training on temporal arteritis diagnosis and management. |
8.3 Patient satisfaction with access to information and support services for temporal arteritis in the UK. |
9 United Kingdom (UK) Temporal Arteritis Market - Opportunity Assessment |
9.1 United Kingdom (UK) Temporal Arteritis Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.2 United Kingdom (UK) Temporal Arteritis Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 United Kingdom (UK) Temporal Arteritis Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 United Kingdom (UK) Temporal Arteritis Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United Kingdom (UK) Temporal Arteritis Market - Competitive Landscape |
10.1 United Kingdom (UK) Temporal Arteritis Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Temporal Arteritis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here